Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion. [PDF]
Linghu D +18 more
europepmc +1 more source
mGBP2 engages Galectin-9 for immunity against Toxoplasma gondii. [PDF]
Kravets E +7 more
europepmc +1 more source
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target. [PDF]
Llaó-Cid L +31 more
europepmc +1 more source
Dichotomous effects of Galectin-9 in disease modulation in murine models of inflammatory bowel disease. [PDF]
Tull S +12 more
europepmc +1 more source
Tumor-derived exosomal tsRNA 3'tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma. [PDF]
Zhao G +6 more
europepmc +1 more source
The regulating role of galectin-9 in immune cell populations. [PDF]
Cao Z, Leng P, Xu H, Li X.
europepmc +1 more source
Bioengineering Platelets Presenting PD-L1, Galectin-9 and BTLA to Ameliorate Type 1 Diabetes. [PDF]
Ma Y +14 more
europepmc +1 more source
Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir Decay. [PDF]
Serrano-Villar S +11 more
europepmc +1 more source
Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma. [PDF]
Shil RK, Mohammed NBB, Dimitroff CJ.
europepmc +1 more source

